Timber pharmaceuticals provides business update and announces fourth quarter and year end 2022 financial results

- lead asset tmb-001 is only compound to receive official orphan drug designation from european commission for two severe subtypes of congenital ichthyosis, arci and xlri -
TMBR Ratings Summary
TMBR Quant Ranking